ABSTRACT
Purpose Provider-to-provider emergency department telehealth (tele-ED) has been proposed to improve rural sepsis care. The objective of this study was to measure the association between sepsis documentation and tele-ED use, treatment guideline adherence, and mortality.
Materials and Methods This analysis was a multicenter (n=23) cohort study of sepsis patients treated in rural emergency departments (EDs) that participated in a tele-ED network between August 2016 and June 2019. The primary exposure was whether sepsis was recognized in the local ED, and the primary outcome was rural tele-ED use, with secondary outcomes of time to tele-ED use, 3-hour guideline adherence, and in-hospital mortality.
Results Data from 1,146 rural sepsis patients were included, 315 (27%) had tele-ED used, and 415 (36%) had sepsis recognized in the rural ED. Sepsis recognition was not independently associated with higher rates of tele-ED use (adjusted odds ratio [aOR] 1.23, 95% CI 0.90–1.67). Sepsis recognition was associated with earlier tele-ED activation (adjusted hazard ratio [aHR] 1.69, 95% CI 1.34-2.13), lower 3-hour guideline adherence (aOR 0.73, 95% CI: 0.55-0.97), and lower in-hospital mortality (aOR 0.72, 95% CI: 0.54-0.97).
Conclusions Sepsis recognition in rural EDs participating in a tele-ED network was not associated with tele-ED use.
Competing Interest Statement
LM, AB, and KD are employed by an organization that provides direct telehealth services. All other authors report no conflicts of interest.
Funding Statement
This study was funded by the Agency for Healthcare Research and Quality (K08HS025753), the Institute for Clinical and Translational Science at the University of Iowa through a grant from the National Center for Advancing Translational Sciences at the National Institutes of Health (UL1TR002537), and the University of Iowa Department of Emergency Medicine. Dr. Mohr is additionally supported by funding from the Rural Telehealth Research Center with funding from the Health Resources and Services Administration (U3GRH40003). These contents are solely the responsibility of the authors and do not necessarily reflect the views of the Agency for Healthcare Research and Quality, the Health Resources and Services Administration, or any other funding agency.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of the University of Iowa gave ethical approval for this work under waiver of informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Institution Where the Work was Performed: University of Iowa Carver College of Medicine, Iowa City, Iowa.
Competing Interests and Source of Funding: LM, AB, and KD are employed by an organization that provides direct telehealth services. All other authors report no competing interests. This study was funded by the Agency for Healthcare Research and Quality (K08HS025753), the Institute for Clinical and Translational Science at the University of Iowa through a grant from the National Center for Advancing Translational Sciences at the National Institutes of Health (UL1TR002537), and the University of Iowa Department of Emergency Medicine. Dr. Mohr is additionally supported by funding from the Rural Telehealth Research Center with funding from the Health Resources and Services Administration (U3GRH40003). These contents are solely the responsibility of the authors and do not necessarily reflect the views of the Agency for Healthcare Research and Quality, the Health Resources and Services Administration, or any other funding agency. Funding agencies had no role in the study design, data analysis or interpretation, writing the report, or the decision to publish.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
